[The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment]

scientific article published on 30 May 2018

[The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment] is …
instance of (P31):
scholarly articleQ13442814

External links are
P932PMC publication ID6219245
P698PubMed publication ID30465031

P50authorPaolo BonanniQ47135409
Donatella PanattoQ53193866
Daniela AmiciziaQ59767479
Piero Luigi LaiQ61658992
P2093author name stringAlessandro Rinaldi
Angela Bechini
Anna Maria Ferriero
Francesco Saverio Mennini
Sara Boccalini
Andrea Marcellusi
Federico Manzi
Chiara Bini
Gino Sartor
Maddalena Innocenti
Emanuela Rizzitelli
Francesca Trippi
Francesca Zangrillo
Giovanni Checcucci Lisi
Mariasilvia Iovine
P2860cites workA Retrospective Cohort Study of the Incidence, Health Care Resource Utilization and Costs of International Classification of Diseases, Clinical Modification, 9th Revision Diagnosed Influenza and Related Complications in US ChildrenQ95816388
Impact of influenza infection in healthy children examined as outpatients and their familiesQ83945158
Vaccines against influenza WHO position paper – November 2012Q85607288
[The concept of Health Literacy and its importance for nursing]Q87046796
Epidemiology and etiology of childhood pneumoniaQ22241278
Vaccines for preventing influenza in healthy childrenQ24201525
Vaccines for preventing influenza in healthy childrenQ24243174
The evolution of human influenza virusesQ24522380
Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analysesQ24614487
How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?Q26748155
Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982–2012: A Systematic AnalysisQ26751854
The safety of influenza vaccines in children: An Institute for Vaccine Safety white paperQ26773027
Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradientsQ27302304
Vaccine coverage in Italy and assessment of the 2012-2014 National Immunization Prevention PlanQ28269077
The use of social networking sites for public health practice and research: a systematic reviewQ28660520
I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in EuropeQ28742719
Influenza-related mortality trends in Japanese and American seniors: evidence for the indirect mortality benefits of vaccinating schoolchildrenQ28743079
Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysisQ28748161
Mortality associated with influenza and respiratory syncytial virus in the United StatesQ29615578
Influenza-associated hospitalizations in the United StatesQ29619463
Incidence, seasonality and mortality associated with influenza pneumonia in Thailand: 2005-2008.Q30227419
Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010.Q30353232
Inactivated and adjuvanted influenza vaccines.Q30364870
Social contact networks for the spread of pandemic influenza in children and teenagersQ30367764
Ten years (2004-2014) of influenza surveillance in Northern ItalyQ30369473
Incubation periods of acute respiratory viral infections: a systematic review.Q30376497
Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis.Q30379228
Complications of seasonal and pandemic influenza.Q30382814
Age-specific differences in influenza A epidemic curves: do children drive the spread of influenza epidemics?Q30403017
Influenza myocarditis and myositis: case presentation and review of the literatureQ30403565
Burden of the 1999-2008 seasonal influenza epidemics in Italy: comparison with the H1N1v (A/California/07/09) pandemic.Q30407148
A pharmacoeconomic appraisal of the strategy to tackle the H1N1v (A/California/07/09) pandemic in Italy: relevance of the CIRI-IV surveillance system.Q30408354
Relationship between the population incidence of febrile convulsions in young children in Sydney, Australia and seasonal epidemics of influenza and respiratory syncytial virus, 2003-2010: a time series analysisQ30408657
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysisQ30408691
Identifying strategies to increase influenza vaccination in GP practices: a positive deviance approach.Q39879668
Influenza: its antigenic variation and ecologyQ40031533
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza SeasonQ40070473
Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the CommunityQ40075443
The future of best investing in vaccines: the Health Technology Assessment approachQ40121721
Trends of influenza B during the 2010-2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisation strategy.Q40122593
Rationale for two influenza B lineages in seasonal vaccines: A meta-regression study on immunogenicity and controlled field trialsQ40143562
Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007.Q40311136
Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15.Q40355918
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season resultsQ40357312
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled studyQ40373417
Influenza A and febrile seizures in childhood.Q40463397
The underrecognized burden of influenza in young children.Q40475111
Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002-2003.Q40521075
Influenza A and B virus infections in childrenQ40567104
Influenza A infection is an important cause of febrile seizuresQ40595648
Influenza vaccine in healthy preschool childrenQ40603983
Prevention and Control of Seasonal Influenza with VaccinesQ40607746
Assessment of effectiveness of VaxigripQ40633500
Febrile Seizure Risk After Vaccination in Children 6 to 23 MonthsQ40713270
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season resultsQ40802753
Febrile Seizure Risk after Vaccination in Children One to Five Months of Age.Q41928717
Influenza vaccine use to protect healthy children: A debated topicQ41934389
The Spectrum and Burden of Influenza-Associated Neurological Disease in Children: Combined Encephalitis and Influenza Sentinel Site Surveillance From Australia, 2013-2015.Q41987697
Acute otitis media and respiratory virus infectionsQ42153237
Immunogenicity and safety of inactivated quadrivalent and trivalent influenza vaccines in children 18-47 months of age.Q42181750
Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trialQ42239677
Influenza-associated pediatric deaths in the United States, 2004-2012.Q42259236
Emergency Department demand associated with seasonal influenza, 2010 through 2014, New South Wales, Australia.Q42374407
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing homeQ42905616
Molecular monitoring of causative viruses in child acute respiratory infection in endemo-epidemic situations in ShanghaiQ43173658
Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in JapanQ43177217
Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in childrenQ43177458
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.Q43207722
The Japanese experience with vaccinating schoolchildren against influenzaQ43209480
TYPE B INFLUENZA IN SINGAPORE.Q43210721
A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001–2002 influenza seasonQ43210853
An epidemic of influenza B in AustraliaQ43681796
Vaccine effectiveness against laboratory-confirmed influenza in infants: A matched case control studyQ44110746
Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the vaccine adverse event reporting systemQ44194786
High costs of influenza: Direct medical costs of influenza disease in young childrenQ44816877
Role of non-traditional locations for seasonal flu vaccination: Empirical evidence and evaluationQ45057572
Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.Q45218285
Molecular epidemiology of influenza B virus among hospitalized pediatric patients in Northern Italy during the 2015-16 season.Q45326028
Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity?Q45397635
Epidemiology and molecular characterization of influenza viruses, human parechoviruses and enteroviruses in children up to 5 years with influenza-like illness in Northern Italy during seven consecutive winter seasons (2010-2017).Q46268239
Clinical manifestations and socio-economic impact of influenza among healthy children in the communityQ46606837
Estimates of global seasonal influenza-associated respiratory mortality: a modelling studyQ46876629
Characteristics and outcomes of influenza-associated encephalopathy cases among children and adults in Japan, 2010-2015.Q47182048
Impact of live attenuated influenza vaccination programme for healthy children in Northern Ireland: A comparison of seven influenza seasons, 2010/11-2016/17.Q47185746
Estimating the Population Impact of a New Pediatric Influenza Vaccination Program in England Using Social Media Content.Q47187065
Why do we not want to recommend influenza vaccination to young children? A qualitative study of Australian parents and primary care providersQ47195857
Preventing influenza in younger childrenQ30420046
Neurologic complications of influenzaQ30420315
Renal complications of seasonal and pandemic influenza A virus infectionsQ30422342
The burden of seasonal and pandemic influenza in infants and childrenQ30430303
Impact of seasonal and pandemic influenza on emergency department visits, 2003-2010, Ontario, CanadaQ30430972
Characterization of a novel influenza virus in cattle and Swine: proposal for a new genus in the Orthomyxoviridae familyQ30770154
Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic reviewQ30847472
Public health literacy definedQ33429448
Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled studyQ33434855
Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season.Q33553117
In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigenQ33820732
Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009.Q34047266
Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance systemQ34099150
Influenza hemagglutinin and neuraminidase membrane glycoproteinsQ34121109
School-located influenza vaccination decreases laboratory-confirmed influenza and improves school attendanceQ34137789
Risk factors of influenza transmission in householdsQ34249434
Burden of paediatric influenza in Western Europe: a systematic reviewQ34475023
Clinical characteristics of acute viral lower respiratory tract infections in hospitalized children in Seoul, 1996-1998.Q34655701
Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adultsQ34729188
Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysisQ34783486
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 yearsQ34862926
The clinical and etiological characteristics of influenza-like illness (ILI) in outpatients in Shanghai, China, 2011 to 2013Q35231245
Mortality in children from influenza and respiratory syncytial virusQ35559491
Promotion of influenza vaccination among health care workers: findings from a tertiary care children's hospital in Italy.Q35708648
Epidemiological and virological characteristics of influenza B: results of the Global Influenza B StudyQ35740809
An Innovative Pseudotypes-Based Enzyme-Linked Lectin Assay for the Measurement of Functional Anti-Neuraminidase AntibodiesQ35744237
Influenza vaccination among healthcare workers in ItalyQ35886973
Low vaccination coverage among italian healthcare workers in 2013.Q35887577
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.Q35906893
Could university training and a proactive attitude of coworkers be associated with influenza vaccination compliance? A multicentre survey among Italian medical residents.Q35910128
Safety of the trivalent inactivated influenza vaccine among children: a population-based studyQ35936147
Strategies to increase influenza vaccination rates: outcomes of a nationwide cross-sectional survey of UK general practiceQ35981831
Age-specific differences in influenza virus type and subtype distribution in the 2012/2013 season in 12 European countries.Q36129250
Incidence of influenza and associated illness in children aged 0-19 years: a systematic reviewQ36264226
Immunization attitudes and beliefs among parents: beyond a dichotomous perspective.Q47302554
Viral etiologies and epidemiology of patients with acute respiratory infections based on sentinel hospitals in Gansu Province, Northwest China, 2011-2015.Q47547249
Acute Myocardial Infarction after Laboratory-Confirmed Influenza InfectionQ47549279
Vaccines for preventing influenza in healthy childrenQ47638511
Burden of influenza in children in the communityQ47924586
Human metapneumovirus and lower respiratory tract disease in childrenQ47990064
Incidence of outpatient visits and hospitalizations related to influenza in infants and young children.Q48012524
The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy.Q48145472
Health literacy and vaccination: A systematic reviewQ48161399
Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trialQ49057993
Health literacy, emotionality, scientific evidence: Elements of an effective communication in public health.Q49580188
Influenza-Associated Pediatric Deaths in the United States, 2010-2016.Q50026189
Parental vaccine hesitancy in Italy - Results from a national survey.Q50079937
Updates on Influenza Vaccination in ChildrenQ50180208
Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older AdultsQ50420352
Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study.Q50690322
Risk Communication, Values Clarification, and Vaccination Decisions.Q50915746
Population-wide benefits of routine vaccination of children against influenza.Q51980197
Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families.Q52547725
The Influence of Provider Communication Behaviors on Parental Vaccine Acceptance and Visit Experience.Q54463592
Confidence in vaccination: a parent model.Q54522494
Influenza Vaccination Strategies Should Target ChildrenQ56794483
A revision of the system of nomenclature for influenza viruses: a WHO memorandumQ56941030
InfluenzaQ57120491
Influenza-Associated Deaths among Children in the United States, 2003–2004Q57385012
Influenza vaccine in healthy children: a meta-analysisQ57560041
Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasonsQ57927674
The burden of influenza B: a structured literature reviewQ57943670
The ethics of influenza vaccinationQ58659412
Quadrivalent inactivated influenza vaccine (VaxigripTetra™)Q59351929
Prevalence of Various Respiratory Viruses in the Middle Ear during Acute Otitis MediaQ59506045
Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young ChildrenQ61848833
Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981Q69262720
Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary diseaseQ72205122
The incidence, natural history and associated outcomes of influenza-like illness and clinical influenza in ItalyQ77337552
Prophylactic effect of inactivated influenza vaccine on young childrenQ78024894
Effectiveness of school-based influenza vaccinationQ79431476
The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study qualityQ79679969
Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002-2003 seasonQ81235322
Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 dosesQ81920819
Parental perception of influenza in Italy: a web surveyQ82408666
Commentary: benefits of influenza vaccine in US elderly--new studies raise questionsQ36348297
Estimating influenza hospitalizations among childrenQ36403778
Detection of influenza C virus but not influenza D virus in Scottish respiratory samplesQ36456135
Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virusQ36470030
Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.Q36633877
A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 yearsQ36846234
Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasonsQ36964157
Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United StatesQ36977877
Facebook Advertising Across an Engagement Spectrum: A Case Example for Public Health Communication.Q37000260
Introduction of a quadrivalent influenza vaccine in Italy: a budget impact analysisQ37011575
Influenza-associated central nervous system dysfunction: a literature reviewQ37166293
An observational study of febrile seizures: the importance of viral infection and immunization.Q37470267
Attitudinal variables and a possible mediating mechanism for vaccination practice in health care workers of a local hospital in L'Aquila (Italy)Q37619146
Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy.Q37669436
The need for quadrivalent vaccine against seasonal influenzaQ37780348
Influenza-related viral myocarditisQ37800086
Effectiveness and safety of influenza vaccination in children: European perspectiveQ37912505
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysisQ37955413
The rationale for quadrivalent influenza vaccinesQ37976542
Effects of influenza on pregnant women and infantsQ38037607
Acute sinusitis in childrenQ38088457
The evolving history of influenza viruses and influenza vaccinesQ38136296
A review of the indirect protection of younger children and the elderly through a mass influenza vaccination program in JapanQ38241368
Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trialQ38375196
Management of two influenza vaccination campaign in health care workers of a university hospital in the south ItalyQ38401703
Fluarix quadrivalent vaccine for influenzaQ38534169
Influenza as a trigger for cardiovascular disease: An investigation of serotype, subtype and geographic locationQ38800824
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studiesQ38803189
Clinician-parent discussions about influenza vaccination of children and their association with vaccine acceptanceQ38845565
Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.Q38928500
Facilitators and barriers of parental attitudes and beliefs toward school-located influenza vaccination in the United States: Systematic reviewQ39188630
Influenza vaccination of schoolchildren and influenza outbreaks in a schoolQ39204971
Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sampleQ39352336
Parental knowledge, attitudes and behaviours towards influenza A/H1N1 in Italy.Q39713558
P433issue1 Suppl 1
P921main subjectItalyQ38
P304page(s)E1-E86
P577publication date2018-05-30
P1433published inJournal of preventive medicine and hygieneQ26842091
P1476title[The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment]
P478volume59

Reverse relations

cites work (P2860)
Q90092650Virological Surveillance of Influenza in the eight epidemic seasons after the 2009 pandemic in Emilia-Romagna (Northern Italy)
Q89668848[Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy]

Search more.